Compound-Protein Representations for Flexible Bioactivity Prediction

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional machine learning systems for predicting biological interactions between genes, compounds, and proteins suffer from inaccuracies, inefficiencies, and operational inflexibility, particularly in generating accurate and flexible bioactivity predictions.

Innovation Solution

A protein interaction learning system utilizes a compound-protein interaction machine learning model to generate a machine learning representation, which trains target machine learning models to predict bioactivity results and identifies contributing proteins through explainability models, improving accuracy, flexibility, and efficiency.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If conventional machine learning systems utilize large volumes of training data to generate predictions, then the coverage of biological interactions is improved, but the accuracy and efficiency deteriorate

Engineering Contradiction:
Improvevolume of training dataVSAvoidprediction accuracy
Core Design Contradiction:
Quantity of substanceVSMeasurement precision

Solution Approach 1:

The patent introduces compound-protein machine learning representations as an intermediary layer between raw training data and final bioactivity predictions. These representations encode interaction patterns in a condensed format, serving as a mediator that transforms large-volume raw data into concentrated, informative features that improve prediction accuracy without requiring proportional increases in data volume.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The system combines multiple types of information (compound features, protein features, and interaction patterns) into composite compound-protein machine learning representations. This composite approach integrates diverse data sources into a unified representation that captures complex biological interactions more effectively than single-source features, thereby improving prediction accuracy.

Inventive Principle:
Principle #40Composite materials

2Quantity of substance

If conventional machine learning systems utilize large volumes of training data to generate predictions, then the coverage of biological interactions is improved, but the computational efficiency deteriorates

Engineering Contradiction:
Improvevolume of training dataVSAvoidcomputational efficiency
Core Design Contradiction:
Quantity of substanceVSProductivity

Solution Approach 1:

The patent extracts essential interaction patterns from large volumes of training data and consolidates them into compact compound-protein machine learning representations. This extraction process separates the critical information from the voluminous raw data, retaining only the most relevant features for prediction while discarding redundant information, thereby improving computational efficiency.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The system transforms the parameter representation from raw high-dimensional training data to condensed machine learning representations with optimized feature dimensions. This parameter transformation reduces the computational complexity by changing the representation format to one that requires fewer computational resources for processing while maintaining predictive power.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If conventional machine learning systems are designed for specific prediction tasks, then the specialization is improved, but the operational flexibility deteriorates

Engineering Contradiction:
Improvetask specializationVSAvoidoperational flexibility
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent creates compound-protein machine learning representations that serve multiple functions across different prediction tasks. These representations are universally applicable to various bioactivity prediction problems (ADMET predictions, biological perturbation programs, etc.), allowing a single representation framework to support multiple specialized tasks without requiring separate models for each application.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The system employs dynamic target machine learning models that can be trained and adapted to different specific tasks using the same compound-protein representations. The models can dynamically adjust their parameters and configurations based on the specific prediction task at hand, enabling both specialization for individual tasks and flexibility across multiple applications.

Inventive Principle:
Principle #15Dynamics

Data Source

PatentUS20260038647A1Utilizing compound-protein machine learning representations to generate bioactivity predictions
Publication Date: 2026.02.05 RECURSION PHARMACEUTICALS INC
  • US20260038647A1 patent drawing
  • US20260038647A1 patent drawing
  • US20260038647A1 patent drawing

AI summary

The present disclosure relates to systems, non-transitory computer-readable media, and methods that utilizing compound-protein machine learning representations to generate target results. For example, the disclosed systems can utilize a compound-protein interaction machine learning model to generate a compound-protein machine learning representation for compound protein pairs. The disclosed systems can utilize the compound-protein machine learning representation to train and utilize other target machine learning models in generating predicted bioactivity results. For example, the disclosed systems train a target machine learning model from compound-protein machine learning representations to generate ADMET predictions and/or biological perturbation program predictions. Furthermore, the disclosed systems can utilize one or more explainability models in conjunction with target machine learning models trained based on compound-protein machine learning representations to identify proteins that contribute to predicted bioactivity results.